These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 10260197)
1. Age: a growing P & T concern. Lipman AG Hosp Formul; 1983 May; 18(5):475. PubMed ID: 10260197 [No Abstract] [Full Text] [Related]
2. Mission, role, and functions of the P & T Committee. Bell JE; Evans PJ; Standish RC Hosp Formul; 1983 Jun; 18(6):639-40, 643-6. PubMed ID: 10260202 [TBL] [Abstract][Full Text] [Related]
3. The goals and functions of a P & T committee. Sudds TW; Williams RR Hosp Formul; 1985 Nov; 20(11):1163-5, 1171, 1174. PubMed ID: 10274572 [TBL] [Abstract][Full Text] [Related]
4. Adverse drug reactions and the P & T committee. Lipman AG Hosp Formul; 1980 Jul; 15(7):580. PubMed ID: 10247654 [No Abstract] [Full Text] [Related]
5. Developing an effective P & T Committee, Part 2. Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830 [TBL] [Abstract][Full Text] [Related]
6. [Drug committee: committee is going to bring about a more knowledgeable attitude to the selection of drugs]. Hagelsten JO Sygeplejersken; 1978 Mar; 78(12):4-7, 20. PubMed ID: 247708 [No Abstract] [Full Text] [Related]
7. Effective decision-making in a changing healthcare environment: a P & T Committee interview. Zoloth A; Yon JL; Woolf R Hosp Formul; 1989 Feb; 24(2):85-7, 90, 93 passim. PubMed ID: 10291815 [TBL] [Abstract][Full Text] [Related]
9. The evolutionary role of the pharmacy and therapeutics committee in technology assessment. Mehr SR Manag Care Interface; 2006 Jan; 19(1):42-5. PubMed ID: 16453995 [TBL] [Abstract][Full Text] [Related]
10. The Drug Spotlight Program. Aagaard GN J Assoc Hosp Med Educ; 1978; 1st Quarter():58-60. PubMed ID: 10307276 [No Abstract] [Full Text] [Related]
11. P & T Committee role in advocating rational therapeutics. Borreson R Hosp Formul; 1986 May; 21(5):590-8. PubMed ID: 10311625 [TBL] [Abstract][Full Text] [Related]
12. Editors' roundtable: Current formulas for P & T Committee success (Part 1). Lipman AG; Neu HC; Singh BN; Weintraub M Hosp Formul; 1987 Mar; 22(3):288-98. PubMed ID: 10312015 [TBL] [Abstract][Full Text] [Related]
13. The P&T committee and drug use review. Provost GP Hosp Formul; 1979 May; 14(5):596, 594. PubMed ID: 10242199 [No Abstract] [Full Text] [Related]
14. Physician dispensing: P & T Committee implications. Weintraub M; Lipman AG Hosp Formul; 1987 Jul; 22(7):607, 610. PubMed ID: 10282680 [No Abstract] [Full Text] [Related]
15. Challenges in the anticipation of biosimilars: how must a P&T committee gear up? Tadlock C Manag Care Interface; 2007 Apr; 20(4):12, 14. PubMed ID: 17536251 [No Abstract] [Full Text] [Related]
16. Drug utilization reviews--a major responsibility of the P&T committee: an administrative overview. Godwin HN Hosp Formul; 1981 Jun; 16(6):609, 613-5. PubMed ID: 10251441 [No Abstract] [Full Text] [Related]
17. Patient drug safety requires P and T attention to these guidelines. Myers RS Mod Hosp; 1968 Nov; 111(5):104 passim. PubMed ID: 5712126 [No Abstract] [Full Text] [Related]
19. The other side of the fence: hospital P&T committee members' role in drug selection. Archambault GF Med Mark Media; 1978 May; 13(5):48, 50, 52 passim. PubMed ID: 10307029 [No Abstract] [Full Text] [Related]
20. Formulary management to reduce cost: P & T committee strategies. Roberts MJ; Summerfield MR Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]